SYDNEY & MOUNTAIN VIEW, Calif.–DNAnexus Inc., the global leader in genome informatics and data management, today announced that the Garvan Institute of Medical Research in Sydney, Australia has selected the DNAnexus Platform to power its new Genome.One clinical whole genome testing company.

“Our vision at Garvan is to make genomic information available and beneficial to all, whether in research or clinical settings,” said Marcel Dinger, Head of the Garvan Institute’s Kinghorn Centre for Clinical Genomics. “Our centre has been using the DNAnexus Platform for its genomics-based research initiatives. A key component in our pipeline was the ability to securely manage a tremendous amount of sensitive data.”“We are proud to be the bioinformatics platform powering one of the world’s first clinical whole genome testing services, and to help Garvan expand their business with a new clinical diagnostics company,” said Richard Daly, CEO of DNAnexus. “By relying on DNAnexus’ proven technology platform to securely